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In our  previous  studies,  quantiﬁed  saponins-rich  fraction  from  adventitious  root  extract  of  Ficus  religiosa
L.,  Moraceae,  showed  anticonvulsant  effect  in acute,  as  well  as chronic  mice  models  of  epilepsy. The
present  study  was  designed  to reveal  putative  anticonvulsant  mechanism  of  quantiﬁed  saponins-rich
fraction  using  target  speciﬁc  animal  models.  The  anticonvulsant  effect  of  quantiﬁed  saponins-rich  frac-
tion  was initially  studied  in maximal  electroshock  and  pentylenetetrazol  test  at 1, 2  and  4 mg/kg;  i.p.  doses.
Based  on  the  results  of  initial  anticonvulsant  testing,  different  groups  of  mice  were  injected  with  vehicle
or  quantiﬁed  saponins-rich  fraction  (4 mg/kg;  i.p.),  30 min  prior  to an  injection  of  N-methyl-d-aspartic
acid  (100  mg/kg;  s.c.),  bicuculline  (5 mg/kg;  i.p.),  strychnine  hydrochloride  (2 mg/kg;  i.p.), BAY  k-8644
(37.5  g; i.c.v.),  veratridine  (500  g/kg;  i.p.)  and  the  convulsive  episodes  were  studied.  Treatment  with  the
extract  (1, 2 and  4  mg/kg)  showed  signiﬁcant  protection  in  maximal  electroshock  and  pentylenetetrazol-
induced  convulsion  tests,  in a dose-dependent  manner.  Moreover,  quantiﬁed  saponins-rich  fraction  at
4 mg/kg  dose  showed  signiﬁcant  increase  in latency  to  clonic  convulsions,  decrease  in seizure  severity
and  increase  in  average  wave  amplitude  in  bicuculline,  BAY  k-8644  and  veratridine  tests,  respectively,
as  compared  to vehicle  control.  However,  SRF  treatment  failed  to abolish  N-methyl-d-aspartic  acid  and
strychnine-induced  convulsions,  indicated  by  insigniﬁcant  change  in  the  appearance  of  turning  behavior
and  onset  of tonic  extension,  respectively,  as  compared  to  vehicle  control.  From  the results  of  present
study,  it is concluded  that  quantiﬁed  saponins-rich  fraction  suppress  maximal  electroshock,  pentylenete-
trazol,  bicuculline,  BAY  k-8644  and  veratridine-induced  convulsions,  indicating  its  GABAergic,  Na+ and
Ca2+ channel  modulatory  effects.  Further  it can  be correlated  that  quantiﬁed  saponins-rich  fraction  causes
deactivation  of  voltage-gated  Na+ and  Ca2+ channels,  without  effecting  ligand-gated  Na+ and  Ca2+ chan-
nels.  More  studies  are  required  at molecular  levels  using  in vitro  techniques  to  understand  the exact
molecular  interactions  of  quantiﬁed  saponins-rich  fraction  with  these  pathways.
©  2016  Sociedade  Brasileira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
he  CCaccess  article  under  t
ntroduction
Ficus religiosa L., Moraceae, is a medicinally important plant
f the genus Ficus, and has been extensively used in traditional
edicine for a wide range of ailments. Its different botanical
arts have been used for the ethnomedical treatment of epilepsy.
any of its traditional uses have been validated in different
xperimental studies throughout the globe. Its different parts have
hown a variety of neurological effects including antiamnesic,
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acetylcholinesterase inhibitory, parasympathetic modulatory,
antianxiety and reversal of reserpine-induced behavioral effects
(Singh et al., 2011a). Apart from these pharmacological effects, it
has also been studied for its anticonvulsant potential in different
experimental studies.
In our previous study, the crude fruit extract of F. religiosa
have shown anticonvulsant activity, which was found to be due
to modulation of serotonergic functions of the brain (Singh and
Goel, 2009; Goel and Singh, 2013). The ﬂavonoid-rich fraction
of the fruit extract in combination with phenytoin also showed
protection in kindling mice model, along with attenuation of
associated cognitive and behavioral impairments (Singh et al.,
2014a). Its leaf extract was  studied in acute animal models of
convulsion, but was found to be ineffective (Singh et al., 2011b).
In a recent study the crude bark extract of the plant also showed
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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rotection in acute animal models of convulsions, which was found
o be due to GABA aminotransferase inhibitory activity of its bioac-
ive metabolites (Singh et al., 2014b). The crude adventitious root
xtract of F. religiosa has also been studied for its anticonvulsant
ctivity (Patil et al., 2011). When partitioned, only the saponins-rich
raction (SRF) of the extract retained anticonvulsant activity, rest
ll other fractions were found to ineffective. The study indicated
aponins present in the adventitious root extract to be responsible
or its activity (Singh et al., 2012). SRF per se also prevented behav-
oral impairments associated with kindling in mice, but failed to
revent cognitive deﬁcit (Singh et al., 2013).
The saponins are a type of naturally occurring surface-active gly-
osides, which are generally produced by plants with an exception
f some lower marine animals and bacteria (Francis et al., 2002).
he therapeutic role of saponins has been suggested in several
entral as well as peripheral pathological conditions like, neu-
odegeneration, epilepsy, cognitive impairments, hypertension,
therosclerosis, inﬂammation, allergic reactions, cancer, hyper-
lycemia and many more (Radad et al., 2004; Nah et al., 2007).
he saponins isolated from other plants have been found to inter-
ct with all the pathological processes involved in epilepsy. They
howed GABAergic agonist (Kimura et al., 1994; Kim et al., 2001;
hoi et al., 2003), glutamatergic antagonist (Kim and Rhim, 2004;
eng et al., 2009), glycinergic agonist (Noh et al., 2003; Kim et al.,
004), Ca2+ (Zhong et al., 1995; Kim et al., 2008) and Na+ channel
lockade effects (Liu et al., 2001; Kim et al., 2005; Chindo et al.,
009). Due to wide spectrum of neuronal pathway interaction by
aponins, the present study was envisaged to understand the puta-
ive anticonvulsant mechanism of SRF of adventitious root extract
f F. religiosa, by using animal models of epilepsy involving pri-
arily modulation of calcium, sodium, glutamate and GABAergic
athways.
ethods
lant material, extraction, fractionation and quantiﬁcation
SRF was prepared and quantiﬁed as described in our previous
tudy (Singh et al., 2012). Brieﬂy, the adventitious roots of Ficus
eligiosa were collected, cleaned, shade-dried, powdered and sub-
ected to repetitive extraction with 50% ethanol in a percolator.
fter drying the combined percolate, the resultant extract was dis-
ersed in water and fractionated with hexane, chloroform, ethyl
cetate and butanol. The butanol fraction was precipitated and the
otal saponins content was determined in the precipitates collected
sing colorimetric method with vanillin-sulphuric acid system, as
iscussed in our previous study. The doses were prepared freshly
efore use and was injected intraperitoneally (i.p.). The doses of
RF were selected based on the results of our previous study (Singh
t al., 2012) and was administered at 1, 2 and 4 mg/kg.
nimals
Male Swiss albino mice, weighing 20–30 g obtained from CCS
aryana Agricultural University, Hisar, were employed in the
resent study. The animals were housed in standard cages and
aintained at room temperature with natural day and night cycles.
he animals were allowed free access to food (standard laboratory
odent’s chow) and water during the study period. All the exper-
ments were conducted between 9 am and 4 pm. All procedures
ere carried out according to the guidelines of Committee for the
urpose of Control and Supervision on Experiments on Animals
CPCSEA), India and approved by the Institutional Animal Ethical
ommittee (no.: 107/99/CPCSEA-2009-4.1).armacognosia 26 (2016) 579–585
Drugs and chemicals
Pentylenetetrazol (PTZ) (dissolved in normal saline), strychnine
hydrochloride (dissolved in normal saline), bicuculline (dissolved
in minimum 0.1 N HCl, volume was make up with normal saline,
pH was  adjusted to 6.65 with NaOH), N-methyl-d-aspartic acid
(NMDA) (dissolved in normal saline) and veratridine (dissolved
in minimum 0.1 N HCl, volume was make up with normal saline,
pH was  adjusted to 6.65 with NaOH) were purchased from
Sigma–Aldrich (St. Louis, MO). Reference drugs, diazepam and
phenytoin were obtained locally from Jackson Laboratories Ltd.
(Amritsar, India) and Cadila Laboratories (Ahmedabad, India),
respectively.
Maximal electroshock (MES)-induced convulsions
Mice in different groups were injected with the varying doses
of SRF (1, 2 and 4 mg/kg; i.p.), vehicle (10 ml/kg; i.p.)  and phenytoin
(25 mg/kg; i.p.). After 30 min  of these treatments, all the groups
were delivered a calibrated (through a current calibrator [Rolex,
Ambala, India]) transauricular electroshock of 56 mA for 0.2 s using
a convulsiometer (Rolex, Ambala, India), via a pair of crocodile ear
clips. The duration of tonic hindlimb extension (seconds) was noted
and was compared with that of vehicle control (Swinyard et al.,
1952).
PTZ-induced convulsions
PTZ at a dose of 75 mg/kg was given to ﬁve different groups of
mice pretreated 30 min  prior with the varying doses of SRF (1, 2 and
4 mg/kg; i.p.), vehicle (10 ml/kg; i.p.)  and diazepam (5 mg/kg; i.p.).
Latency to clonic convulsions (min) was  noted and was compared
with that of vehicle control.
NMDA-induced convulsions
Mice in two  different groups were treated with either vehicle
(10 ml/kg) or SRF (4 mg/kg, i.p.)  30 min  prior to a subcutaneous
injection of NMDA (100 mg/kg). Thereafter, the mice were observed
for the appearance of turning behavior for next 30 min. Turning
behavior was characterized as two  consecutive 360 cycles com-
pleted by the same animal (Bhutada et al., 2010). The test was
performed to determine the role of glutamatergic processes for the
anticonvulsant effect of SRF.
Bicuculline-induced convulsions
Bicuculline was  administered (5 mg/kg; i.p.)  in two  different
groups of mice, 30 min  after treatment with vehicle (10 ml/kg; i.p.)
or SRF (4 mg/kg; i.p.). The mice were observed for the appearance
of clonic–tonic seizures and death for a period of 30 min  after bicu-
culline injection. Antagonism of bicuculline seizures was deﬁned as
the absence/delay of clonic–tonic seizures for 30 min  (Irifune et al.,
2003). The test was  performed to examine the GABAergic effects of
SRF.
Strychnine-induced convulsions
The test was  performed to investigate the involvement of glycin-
ergic pathway for the protective effect of SRF. Two  groups of mice
were injected with vehicle or SRF (4 mg/kg, i.p.), 30 min prior to
the injection of strychnine hydrochloride (2 mg/kg; i.p.). The onset
of tonic extension and mortality was  determined (Löscher and
Schmidt, 1988).
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Fig. 1. Effect different doses of saponins-rich fraction from the adventitious root
extract of Ficus religiosa on the duration of MES-induced tonic hind limb extension.
THLE, tonic hind limb extension; SRF 1, 2 and 4, saponins-rich fraction 1, 2 and
4  mg/kg, respectively.
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AY k-8644-induced convulsions
BAY k-8644 was used to induce convulsions as described by
onVoigtlander et al. (1987) with slight modiﬁcations. A free hand
.c.v. injection of BAY k-8644 (37.5 g/10 l) was made in con-
cious mouse, 30 min  after vehicle (10 ml/kg; i.p.)  or SRF (4 mg/kg;
.p.) treatment by visual location method described by Haley and
cCormick (1957). Brieﬂy, each animal was ﬁrmly griped by tautly
ulling the loose skin behind the head, a midline was  drawn using
 marker through the anterior base of the ears and the injection
as made 2 mm on either side the line. A cross between the left
ye–right ear and right eye–left ear was drawn to locate the mid-
oint to draw midline. The injections were made with hypodermic
eedle of 0.4 mm external diameter attached to a 10 l Hamilton
yringe (Hamilton, Bonaduz, Switzerland). The needle was  covered
ith a polypropylene tube, leaving 3 mm of the tip region, so as to
nsert this portion through the skull into the brain of mouse. The
yringe was held at an angle of around 45 degree to the skull, with
he bevel of needle facing up, pointing in the direction of the tail.
nduced seizures were rated according to a scale devised as stage 1,
cratching and twisting of the forelimbs (score 1); stage 2, rearing
nd walking (score 2); stage 3, intermittent clonic jerks of limbs
ith tonic ﬂexion of fore limbs and tail ﬂexion; stage 4, head bob-
ing with complex grooming actions (licking of fur and scratching);
tage 5, jumping, squeaking and tonic extension of hind limbs; stage
, barrel rolling (Kaur and Goel, 2011). The occurrence of seizure
igns and latency were recorded for 1 h. The test was  performed to
nvestigate the role of Ca2+ channels.
eratridine-induced seizure
Veratridine seizures in mice were induced by the methods
escribed by Otoom et al. (2006) and Otoom and Sequeira (2011),
ith slight modiﬁcations. Two different groups of mice were
reated with vehicle (10 ml/kg; i.p.)  or SRF (4 mg/kg; i.p.), 30 min
rior to an intraperitoneal injection of veratridine (500 g/kg).
fter 15 min  of veratridine administration, electroencephalogram
EEG) recording was performed using a Digital Polygraph (PC-2004,
edicaid System, Chandigarh, India) by the method described by
toom and Sequeira (2011), but using surface electrodes. Average
ave amplitude (V/min) and wave pattern in vehicle control ani-
als were compared with that of normal (naïve) and SRF treated
nimals.
tatistical analysis
All the results were expressed as mean ± SEM. The signiﬁcance
f difference between means was determined using one-way anal-
sis of variance (ANOVA) followed by Tukey’s test in MES, PTZ
nd veratridine tests. Unpaired Student’s t-test was employed
o determine signiﬁcance of difference between mean in NMDA,
icuculline, strychnine and BAY k-8644-induced convulsion tests.
tatistical analysis for the percentage mortality and percentage of
nimals showing turning behavior per group was  performed by
hi-square test. The results were regarded as signiﬁcant at p < 0.05.
esults
ffect on MES-induced convulsions
Treatment with SRF showed signiﬁcant (p < 0.001) dose-
ependent decrease in the duration of tonic hind limb extension
t 1 mg/kg (7.8 ± 0.86 s), 2 mg/kg (4.1 ± 1.2 s), and 4 mg/kg
1.4 ± 0.8 s), as compared to vehicle control, with maximum pro-
ection observed at 4 mg/kg. The anticonvulsant activity of SRFFig. 2. Effect different doses of saponins-rich fraction from the adventitious root
extract of Ficus religiosa on the latency to PTZ-induced convulsions. N/C, no convul-
sions; SRF 1, 2 and 4, saponins-rich fraction 1, 2 and 4 mg/kg, respectively.
at 4 mg/kg was found to be comparable to phenytoin treated
(1.2 ± 0.8 s) group (Fig. 1).
Effect on PTZ-induced convulsions
In PTZ-induced convulsions test, treatment with SRF at 1 mg/kg
(p = 0.017), 2 mg/kg (p < 0.001) and 4 mg/kg (p < 0.001) signiﬁcantly
increased the latency to clonic convulsions, as compared to vehi-
cle control at 5.58 ± 0.14 min, 9.54 ± 0.64 min  and 12.28 ± 1.12 min,
respectively. Similarly, as in MES  test, SRF showed dose-dependent
anticonvulsant effect. SRF was  found to be less effective as that of
standard diazepam, as its treatment only delayed the clonic con-
vulsions, were as diazepam pretreatment completely abolished the
induction of PTZ convulsions (Fig. 2).
Effect on NMDA-induced convulsions
Treatment with SRF showed no protection against convulsions
induced by NMDA, indicated by insigniﬁcant change in the onset
and occurrence of turning behavior in mice as compared to vehicle
control (Fig. 3A and B).
Effect on bicuculline-induced convulsionsIn bicuculline test, treatment with SRF (4.12 ± 0.19 min)
showed signiﬁcant (p < 0.001) increase in the latency to clonic con-
vulsions in mice, as compared to vehicle control (2.25 ± 0.25 min).
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atency to convulsions induced by strychnine. (B) Effect of saponins-rich fraction on
owever, no signiﬁcant protection against mortality was observed
fter treatment with SRF as that of vehicle control (Fig. 4A and B).
ffect on strychnine-induced convulsions
Treatment with SRF showed no protection against convulsions
nduced by strychnine, indicated by insigniﬁcant change in the
atency to convulsions, as compared vehicle control. Moreover, no
igniﬁcant protection was observed on the percentage mortality as
hat of control (Fig. 5A and B).ffect on BAY k-8644-induced convulsions
BAY k-8644, a Ca2+ channel agonist administration in mice
esulted in convulsions with a latency of around 7.28 ± 0.27 minosa on strychnine-induced convulsions. (A) Effect of saponins-rich fraction on the
ercentage mortality; NS, not signiﬁcant; SRF 4, saponins-rich fraction 4 mg/kg.
in vehicle control group. Treatment with SRF, signiﬁcantly
(p < 0.001) increased the latency to BAY k-8644-induced con-
vulsions to 15.85 ± 0.89 min. SRF treatment also signiﬁcantly
(p < 0.001) reduced the seizure severity score to 1.83 ± 0.6, as com-
pared to vehicle control (5.33 ± 0.21) group (Fig. 6A and B).
Effect on veratridine-induced seizure
The vehicle control animals after veratridine treatment showed
signiﬁcantly (p < 0.001) increased average wave amplitude of
77.42 ± 3.84 V/min, as compared to normal (naïve) animals show-
ing the amplitude of 59.11 ± 1.98 V/min. Treatment with SRF
signiﬁcantly (p < 0.001) decreased the average wave amplitude
to 51.68 ± 2.69 V/min, as compared to vehicle control animals
(Figs. 7 and 8).
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iscussion
It is important to study the mechanism of a novel anticon-
ulsant component, as it might act on well-recognized targets
n novel ways and/or by novel combinations of actions on well-
ecognized targets. In some cases, such a practice had revealed
ntirely new antiepileptic targets like topiramate and lamotrigine
Rogawski, 2006a). Hence, to study the anticonvulsant mechanism
f SRF, the present study was carried out. Treatment with SRFsa on BAY k-8644-induced convulsions. (A) Effect of saponins-rich fraction on the
 seizure severity score; SRF 4, saponins-rich fraction 4 mg/kg.
resulted in suppression of MES  and PTZ-induced convulsions in a
dose-dependent manner. The results of this initial screening are
in line with the results of our previous study (Singh et al., 2012).
SRF treatment resulted in marked suppression of BAY k-8644 and
veratridine-induced convulsions, and showed partial protection
against bicuculline-induced convulsion. However it was found to
be totally ineffective against strychnine and NMDA-induced con-
vulsions. Since, MES  and PTZ tests are considered to be the “gold
standards” in early stages of drug testing (Rogawski, 2006b), hence
initial conﬁrmation of the anticonvulsant effect of SRF was carried
in these tests at all doses. The other tests (NMDA, strychnine, bicu-
culline, BAY k-8644 and veratridine-induced convulsion tests) were
performed to investigate its putative anticonvulsant mechanism
and effect in different acute seizure models of varied phenotype.
A single most effective dose was  used to reduce the number of
animals required in the study, due to ethical constraints.
Some of the previous in vitro studies revealed that saponins
isolated from ginseng and other Ficus species causes blockade of
voltage dependent Na+ channels, hence decreases neuronal exci-
tation (Liu et al., 2001; Kim et al., 2005; Chindo et al., 2009).
Hence, to study the effect of SRF on Na+ channels, veratridine-
induced seizure model was  used. Veratridine is a commonly used
experimental tool in various electrochemical studies, it opens Na+
channels during sustained membrane depolarization by inhibi-
ting inactivation, leading to Na+ inﬂux, secondarily it causes Ca2+
inﬂux, increased pump activity and in turn exocytosis, leading to
experimental seizures in rodents (Ulbricht, 1998; Otoom et al.,
2006). In the present study, administration of veratridine in vehi-
cle control animals resulted in seizures, indicated by characteristic
EEG changes, these changes are in line with a previous study
(Otoom and Sequeira, 2011). Several clinically used antiepilep-
tic drugs acting through blockade of Na+ channels, like valproic
acid, phenytoin and carbamazepine have been found to suppress
veratridine-induced abnormal neuronal excitation in experimental
studies (Otoom and Alkadhi, 2000a,b). Since in our study, pretreat-
ment with SRF, abolished the veratridine-induced seizure activity
indicated by normalization of EEG pattern, indicating its effect
might be due to Na+ channel blockade activity.
Panaxatriol saponins, the main constituents extracted from
Panax notoginseng have been reported to possess an inhibitory
action on voltage-gated Ca2+ channels, leading to shortening of
their open time, prolonging the close time, and reducing their
open-state probabilities (Zhong et al., 1995; Kim et al., 2008), sug-
gesting Ca2+ channel antagonist effect of saponins. Ethosuximide,
gabapentin, lamotrigine, oxcarbazepine, topiramate include the
list of clinically used antiepileptics that act through blockade of
Ca2+ channels (Czapin´ski et al., 2005). These literature ﬁnding sug-
gests that, SRF might act through the blockade of Ca2+ channels.
Hence the effect of SRF was studied against convulsions induced
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y BAY k-8644, which induce convulsions through activation of
oltage-gated Ca2+ channels. SRF pretreatment inhibited BAY k-
644-induced convulsion, thereby suggesting its effect to be due to
nhibition of Ca2+ channels.
Several preclinical studies indicating the modulation of GABAer-
ic functions by plant isolated saponins have been reported in
iterature. Saponins isolated from Panax ginseng showed GABAA
eceptor binding in the rat brain (Kimura et al., 1994; Kim et al.,
001). These saponins also increased the GABA-mediated inward
eak current in Xenopus oocytes (Choi et al., 2003). Effectiveness
f SRF in initial anticonvulsant screening in PTZ (GABAA receptor
ntagonist) test indicated its GABAergic modulatory effect. Since
everal other anticonvulsant molecules acting through other mech-
nisms have also shown activity against PTZ convulsions, hence to
urther conﬁrm the GABAergic effect of SRF, its effect was studied in
icuculline (GABAA receptor antagonist) test. Treatment with SRF
esulted in suppression of bicuculline-induced convulsions, indi-
ated by increase in latency to clonic convulsions, but however it
as found to be ineffective in reducing mortality. Further studies
re required to understand the exact GABAergic modulatory effects
f SRF.
Inhibition of NMDA-induced excitatory responses by plant iso-
ated saponins has also been well documented in several studies.
aponins isolated from ginseng have shown inhibition of NMDA
eceptor-mediated epileptic discharges in cultured hippocampal
eurons (Kim and Rhim, 2004). Ginsenoside Rb3 have shown neu-
oprotective role on hippocampal neurons, through facilitation of
a2+-dependent deactivation of NMDA receptors (Peng et al., 2009).
linically used drugs like felbamate and lacosamide act through
nhibition of NMDA receptor (Rogawski, 2006). Therefore, to study
he effect of SRF on NMDA-mediated excitatory responses, NMDA-
nduced convulsions test was used. However SRF failed to suppress
MDA-induced convulsions, indicating lack of NMDA receptor
nteractions of SRF.
The role of glycinergic receptor mechanism in the pathogenesis
f clinical and experimental epilepsies has been well established. In
ifferent studies, the glycinergic drugs have shown suppression of
pileptic discharge (Laube et al., 2002; Chattipakorn and McMahon,
003). Ginsenosides have shown enhancement of glycine-induced
nward peak current in human glycine receptor channel activity
xpressed in Xenopus oocytes (Noh et al., 2003). They have also been
ound to antagonize NMDA receptors through the glycine modu-
atory site in rat cultured hippocampal neurons (Kim et al., 2004).
hese literature ﬁndings suggest the glycinergic effects of saponins.
ence to study the glycinergic modulation of SRF, its effect was
tudied against convulsions induced by strychnine (glycine recep-
or antagonist). Since, the SRF was found to be ineffective in
uppressing strychnine-induced convulsions, thereby indicating
ack of effectiveness as direct interaction with glycinergic pathway.
The results of the present study showed that SRF treatment
nhibited MES-induced convulsions and suppressed BAY k-8644,
eratridine and GABAA receptor antagonists (PTZ and bicuculline)-
nduced convulsions at tested doses, indicating it to be acting
hrough multiple mechanisms as GABA agonist as well as Na+ and
a2+ channels inhibitor. Several clinically used drugs have also
een found to be acting through multiple mechanisms (Köhling,
002). Interestingly, SRF showed protection in BAY k-8644 and
eratridine tests, which act through activation of voltage-gated
a2+ and Na+ channels, respectively, but was found to be ineffec-
ive against convulsions induced by NMDA (receptor-operated ion
hannels) receptor agonist, NMDA. The similar anticonvulsant pro-
le is shown by ethosuximide, a clinically used antiepileptic (Turski
t al., 1990; Otoom and Sequeira, 2011). These results indicated
he effectiveness of SRF in blockade of voltage-gated ion channels
nd ineffectiveness toward ligand-gated Na+ and Ca2+ channels.
ince, veratridine act by depolarization of excitable cells, therebyarmacognosia 26 (2016) 579–585
preventing inactivation of Na+ channels, leading to an increase in
inﬂux of Na+ and Ca2+ (Jordán et al., 2000), therefore it is not exactly
clear that the anticonvulsant effect of SRF is due to blockade of Na+
or Ca2+ channels or both, as it has also shown protection against
seizures induced by BAY k-8644. As, ethosuximide which shows
anticonvulsant effect through the blockade of Ca2+ channels also
suppress veratridine-induced seizures. More studies at molecular
levels are required to understand these effects accurately.
Conclusion
The results of present study concluded that SRF exhibit its anti-
convulsant effect through modulation of GABAergic, Na+ and Ca2+
channel functions. Effectiveness of SRF in BAY k-8644 and ver-
atridine tests indicated its voltage-gated Na+ and Ca2+ channels
inhibitory effects but not ligand-gated Na+ and Ca2+ channels. More
studies are required at molecular levels to understand the exact
molecular interactions of SRF with these pathways.
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